188 related articles for article (PubMed ID: 8721550)
1. Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial.
Jabs DA
Antiviral Res; 1996 Jan; 29(1):69-71. PubMed ID: 8721550
[TBL] [Abstract][Full Text] [Related]
2. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
3. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
4. Advances in treatment for cytomegalovirus retinitis.
Bowers M
BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
[TBL] [Abstract][Full Text] [Related]
5. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
6. Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
Control Clin Trials; 1992 Feb; 13(1):22-39. PubMed ID: 1315661
[TBL] [Abstract][Full Text] [Related]
7. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy improves CMV treatment.
AIDS Alert; 1996 Mar; 11(3):32-3. PubMed ID: 11363244
[TBL] [Abstract][Full Text] [Related]
9. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
10. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
;
N Engl J Med; 1992 Jan; 326(4):213-20. PubMed ID: 1345799
[TBL] [Abstract][Full Text] [Related]
11. Detecting CMV retinitis: know what to look for. Treatment is effective but not pleasant.
AIDS Alert; 1996 Mar; 11(3):suppl 1-2. PubMed ID: 11363248
[TBL] [Abstract][Full Text] [Related]
12. Current management of cytomegalovirus disease in patients with AIDS.
Jacobson MA
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
[TBL] [Abstract][Full Text] [Related]
13. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Jacobson MA; Wulfsohn M; Feinberg JE; Davis R; Power M; Owens S; Causey D; Heath-Chiozzi ME; Murphy RL; Cheung TW
AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
[TBL] [Abstract][Full Text] [Related]
14. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
Desatnik HR; Foster RE; Lowder CY
Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
[TBL] [Abstract][Full Text] [Related]
15. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
[No Abstract] [Full Text] [Related]
16. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
Jacobson MA
AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451
[No Abstract] [Full Text] [Related]
17. Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Kuppermann BD; Flores-Aguilar M; Quiceno JI; Rickman LS; Freeman WR
Arch Ophthalmol; 1993 Oct; 111(10):1359-66. PubMed ID: 8216016
[TBL] [Abstract][Full Text] [Related]
18. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease.
Balfour HH
Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708
[TBL] [Abstract][Full Text] [Related]
20. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
